AMGEN INC Total Revenue

Quick Answer

AMGEN INC reported Total Revenue of $36.75 billion for the year ending 2025.

  • AMGEN INC showed an increase of +10.0% in Total Revenue from 2024 to 2025.
  • This data is from AMGEN INC's annual report (Form 10-K), filed with the SEC on February 13, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: $3.80 billion | Q3 2010: $3.82 billion | Q1 2011: $3.71 billion | Q2 2011: $3.96 billion | Q3 2011: $3.94 billion | Q1 2012: $4.05 billion | Q2 2012: $4.48 billion | Q3 2012: $4.32 billion | Q1 2013: $4.24 billion | Q2 2013: $4.68 billion | Q3 2013: $4.75 billion | Q1 2014: $4.52 billion | Q2 2014: $5.18 billion | Q3 2014: $5.03 billion | Q1 2015: $5.03 billion | Q2 2015: $5.37 billion | Q3 2015: $5.72 billion | Q1 2016: $5.53 billion | Q2 2016: $5.69 billion | Q3 2016: $5.81 billion | Q1 2017: $5.46 billion | Q2 2017: $5.81 billion | Q3 2017: $5.77 billion | Q1 2018: $5.55 billion | Q2 2018: $6.06 billion | Q3 2018: $5.90 billion | Q1 2019: $5.56 billion | Q2 2019: $5.87 billion | Q3 2019: $5.74 billion | Q1 2020: $6.16 billion | Q2 2020: $6.21 billion | Q3 2020: $6.42 billion | Q3 2020: $6.42 billion | Q1 2021: $5.90 billion | Q1 2021: $5.90 billion | Q2 2021: $6.53 billion | Q2 2021: $6.53 billion | Q3 2021: $6.71 billion | Q1 2022: $6.24 billion | Q2 2022: $6.59 billion | Q3 2022: $6.65 billion | Q1 2023: $6.11 billion | Q2 2023: $6.99 billion | Q3 2023: $6.90 billion | Q1 2024: $7.45 billion | Q2 2024: $8.39 billion | Q3 2024: $8.50 billion | Q1 2025: $8.15 billion | Q2 2025: $9.18 billion | Q3 2025: $9.56 billion.
  • Over the full 20 years of available data (2008 to 2025), AMGEN INC's Total Revenue has grown by 145.0%.
  • Historical annual values: Fiscal year 2025: $36.75 billion | Fiscal year 2024: $33.42 billion | Fiscal year 2023: $28.19 billion | Fiscal year 2022: $26.32 billion | Fiscal year 2021: $25.98 billion | Fiscal year 2020: $25.42 billion | Fiscal year 2020: $25.42 billion | Fiscal year 2019: $23.36 billion | Fiscal year 2019: $23.36 billion | Fiscal year 2018: $23.75 billion | Fiscal year 2017: $22.85 billion | Fiscal year 2016: $22.99 billion | Fiscal year 2015: $21.66 billion | Fiscal year 2014: $20.06 billion | Fiscal year 2013: $18.68 billion | Fiscal year 2012: $17.27 billion | Fiscal year 2011: $15.58 billion | Fiscal year 2010: $15.05 billion | Fiscal year 2009: $14.64 billion | Fiscal year 2008: $15.00 billion.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: